Trials / Conditions / Levodopa Induced Dyskinesia (LID)
Levodopa Induced Dyskinesia (LID)
5 registered clinical trials studyying Levodopa Induced Dyskinesia (LID).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia NCT02439203 | Bukwang Pharmaceutical | Phase 2 |
| Completed | Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia NCT02274766 | Adamas Pharmaceuticals, Inc. | Phase 3 |
| Terminated | Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID NCT02153632 | Adamas Pharmaceuticals, Inc. | Phase 3 |
| Completed | Open-Label Safety Study of ADS-5102 in PD Patients With LID NCT02202551 | Adamas Pharmaceuticals, Inc. | Phase 3 |
| Completed | ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) NCT02136914 | Adamas Pharmaceuticals, Inc. | Phase 3 |